NICE INSIGHT REPORT

Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 39 clinical and commercial mRNA development and manufacturing RFP service line items
  • Exhaustive directory of capabilities profiles for the top 75 CDMOs specializing in mRNA development and manufacturing
  • Technical focus on mRNA stability, scaling, processing, and purification technologies
  • Includes Nice Insight’s Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming mRNA-based trials, sourced from the FDA Clinical Trials Database
Learn More
Messenger Ribonucleic Acid, mRNA

Key market insights for innovators, CDMOs and investors in the mRNA industry.

Essential pricing and market intelligence for CDMOs

Compare prices to your competitors with our strategic pricing study, which breaks down the manufacturing process and industry costs. As investments pour in from both the private and government sectors, learn from leaders in mRNA-based drugs so you can better position your business.

 

Grasp the mRNA Vaccine & Therapeutics pipeline

Our Market Analysis provides an in-depth R&D pipeline report segmented by indication and development stage. Make informed business decisions with our guide to approved mRNA drugs and the developmental and clinical landscape. See where your competitors are from pre-clinical through Phase III trials.

Update cookies preferences